Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts. (Q54597907)

1 June 2018

title

Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts. (English)

1 reference

1 June 2018

author name string

Paul Chan

1

1 reference

1 June 2018

Ju-Chi Liu

2

1 reference

1 June 2018

Li-Jen Lin

3

1 reference

1 June 2018

Po-Yuan Chen

4

1 reference

1 June 2018

Tzu-Hurng Cheng

5

1 reference

1 June 2018

Jaung-Geng Lin

6

1 reference

1 June 2018

Hong-Jye Hong

7

1 reference

1 June 2018

publication date

1 January 2011

1 reference

1 June 2018

The American Journal of Chinese Medicine

published in

1 reference

1 June 2018

volume

39

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

page(s)

381-394

1 reference

1 June 2018

Nitric oxide attenuates the expression of transforming growth factor-beta(3) mRNA in rat cardiac fibroblasts via destabilization

cites work

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Investigation of the effect of tanshinone IIA on nitric oxide production in human vascular endothelial cells by fluorescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Cardiac fibroblasts: at the heart of myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Angiotensin II, adhesion, and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

The chemical biology of nitric oxide: implications in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Tanshinone II(A) elicited vasodilation in rat coronary arteriole: roles of nitric oxide and potassium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1142%2FS0192415X11008890

10.1142/S0192415X11008890

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21476213

1 reference

1 June 2018